Subcutaneous Sumatriptan for Refractory Trigeminal Neuralgia
Authors:
- Miwako SaitoMSMiwako Saito
- Sumio HokaSHSumio Hoka
- 5 April 2006
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 46 (4) , 577-582
Abstract
Background.—Mechanical compression of the trigeminal root by an artery is thought to cause trigeminal neuralgia. The 5‐HT 1B/1D receptor agonist may inhibit neurogenic inflammation and vasodilation near the irritated trigeminal root. Objective.—To examine the effectiveness of a 5‐HT 1B/1D receptor agonist, sumatriptan, on a paroxysmal pain in trigeminal neuralgia. Methods.—Twenty‐four patients with trigeminal neuralgia refractory to previous treatment were randomized to receive subcutaneously either 3 mg (1 mL) of sumatriptan or 1 mL of saline placebo. Following a 7‐day period, patients crossed over to receive the alternative treatment. Paroxysmal pain triggered by touching or moving the face was assessed with VAS before and 15 minutes after the treatment. Patients used a descriptive scale to pain‐grade outcome, and asked to note whether the pain returned and how long after therapy it recurred. Results.—Subcutaneous sumatriptan, but not placebo, significantly decreased VAS from 8.3 ± 2.1 to 2.4 ± 3.0 cm (mean ± SD). The number of patients who described their pain as moderately or slightly better was 20 in the sumatriptan group and 1 in the placebo group. The effect of subcutaneous sumatriptan persisted for a median period of 7.9 hours (range: 1–20 hours). Conclusions.—Subcutaneous sumatriptan produced prompt analgesia without serious adverse reactions in patients with trigeminal neuralgia refractory to previous treatment.Keywords
This publication has 18 references indexed in Scilit:
- How does sumatriptan nasal spray perform in clinical practice?Cephalalgia, 1998
- Trigeminal neuralgia: The role of self-sustaining discharge in the trigeminal ganglionPain, 1994
- Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction systemAmerican Heart Journal, 1991
- The Clinical Pharmacology, Pharmacokinetics and Metabolism of SumatriptanEuropean Neurology, 1991
- Comparative Neuropharmacology of Dihydroergotamine and Sumatriptan (GR 43175)Headache: The Journal of Head and Face Pain, 1989
- Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular systemAnnals of Neurology, 1988
- Carbamazepine Side Effects in Children and AdultsEpilepsia, 1987
- Reterogasserian anhydrous glycerol injection therapy in trigeminal neuralgia: observations in 552 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in ratsBrain Research, 1987
- Comparison of Percutaneous Radiofrequency Gangliolysis and Microvascular Decompression for the Surgical Management of Tic DouloureuxNeurosurgery, 1981